<?xml version="1.0" encoding="UTF-8"?>
<p>In the 2,124 samples, the overall seroprevalence of antibodies was 11.2% for H9N2 subtype and 3.9% for H7N9 subtype. Seroprevalence for H5Nx and H6Nx subtypes was lower, ranging from 1.3% to 2.1% for H5Nx and from 0.4% to 2.5% for H6Nx. We did not observe evidence of H10N8 infection (
 <xref rid="T3" ref-type="table">Table 3</xref>).
</p>
